[go: up one dir, main page]

BR9611329A - Apolipoproteìna e2 e tratamento de doença de alzheimer - Google Patents

Apolipoproteìna e2 e tratamento de doença de alzheimer

Info

Publication number
BR9611329A
BR9611329A BR9611329-4A BR9611329A BR9611329A BR 9611329 A BR9611329 A BR 9611329A BR 9611329 A BR9611329 A BR 9611329A BR 9611329 A BR9611329 A BR 9611329A
Authority
BR
Brazil
Prior art keywords
alzheimer
disease
treatment
apolipoproteìna
apolipoprotein
Prior art date
Application number
BR9611329-4A
Other languages
English (en)
Inventor
Vassilis I Zannis
Sergie B Aleshkov
Original Assignee
Kos Pharma Inc
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kos Pharma Inc, Univ Boston filed Critical Kos Pharma Inc
Publication of BR9611329A publication Critical patent/BR9611329A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"APOLIPOPROTEìNA E2 E TRATAMENTO DE DOENçA DE ALZHEIMER"<D>. Apolipoproteína E2 (apoE2) recombinante que se liga ao peptídeo amilóide A<225>.
BR9611329-4A 1995-11-01 1996-10-31 Apolipoproteìna e2 e tratamento de doença de alzheimer BR9611329A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55172295A 1995-11-01 1995-11-01
PCT/US1996/017629 WO1997016458A1 (en) 1995-11-01 1996-10-31 Apolipoprotein e2 and treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
BR9611329A true BR9611329A (pt) 1999-12-28

Family

ID=24202413

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611329-4A BR9611329A (pt) 1995-11-01 1996-10-31 Apolipoproteìna e2 e tratamento de doença de alzheimer

Country Status (7)

Country Link
EP (1) EP0866799A4 (pt)
JP (1) JP2000500332A (pt)
AU (1) AU720446B2 (pt)
BR (1) BR9611329A (pt)
CA (1) CA2236274A1 (pt)
MX (1) MX9803422A (pt)
WO (1) WO1997016458A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6234099A (en) * 1998-10-16 2000-05-08 Introgene B.V. Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein
AU1742200A (en) * 1998-11-25 2000-06-13 Eli Lilly And Company Prevention and treatment of amyloid-associated disorders
CN1315402A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉类前体蛋白结合蛋白14和编码这种多肽的多核苷酸
CN1315439A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉类前体蛋白结合蛋白9和编码这种多肽的多核苷酸
US20070036761A1 (en) * 2003-09-26 2007-02-15 Bales Kelly R Lentiviral apoe2 gene therapy
US20070248599A1 (en) * 2006-02-21 2007-10-25 Jordan Tang Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
WO2010020822A1 (en) * 2008-08-19 2010-02-25 University Of Patras Therapy for apolipoprotein-induced hypertriglyceridemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) * 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
GB9414624D0 (en) * 1994-07-20 1994-09-07 Smithkline Beecham Plc Novel method

Also Published As

Publication number Publication date
CA2236274A1 (en) 1997-05-09
JP2000500332A (ja) 2000-01-18
WO1997016458A1 (en) 1997-05-09
MX9803422A (es) 1998-11-29
AU720446B2 (en) 2000-06-01
AU7552696A (en) 1997-05-22
EP0866799A4 (en) 2000-08-23
EP0866799A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
EP0979074A4 (en) TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS
AR064896A2 (es) Composicion farmaceutica no higroscopica
BR9607669A (pt) Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo
DK0643608T3 (da) Proteinrensning
ATE215379T1 (de) Antifungaleverfahren und mitteln
EP0880597A4 (en) THERAPEUTIC USE OF THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY-5c8
DK0746398T3 (da) Antistofrensning
EP0906310A4 (en) OXADIAZOLE-BENZOSULFONAMIDES AS SELECTIVE BETA-3 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETIS AND OBESITY
BR9812879A (pt) Lente oftálmica
TNSN96066A1 (fr) Proteines obeses (ob) recombinantes
FI964284L (fi) Apolipoproteiini E:n polymorfismi ja Alzheimerin taudin hoito
DE69738138D1 (de) Induktion von immunologischer Toleranz gegen einen therapeutischen Antikörper durch Varianten des therapeutischen Antikörpers
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
ATE312909T1 (de) Diagnostika und behandlungen von peridontalen erkrankungen
BR9611329A (pt) Apolipoproteìna e2 e tratamento de doença de alzheimer
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ES2191728T3 (es) Nueva proteina analoga del receptor de ldl y gen que la codifica.
DK1039931T3 (da) Multivalente rekombinante antistoffer til at behandle HRV infektioner
FR2710539B1 (fr) Ensemble d&#39;aiguille chirurgicale.
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
EP0800396A4 (en) TREATMENT OF HYPERANDROGEN STATES
EP0859761A4 (en) 4-AZASTEROIDS FOR TREATING HYPERANDROGEN STATES
EP0981545A4 (en) TREATMENT OF OSTEOPOROSIS

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal